Page 19 of Healthcare

In FY24, Indian pharmaceutical exports to the U.S. were valued at approximately USD 8 billion, with the industry witnessing an…

Presently, India imposes 10 percent tariff on Pharma imports from the United States. The US doesn’t impose any tariff on…

Jefferies maintains that companies with mixed revenue streams, such as specialty pharma, biosimilars, and inhalers, may face some impact.

Drugmakers have argued that tariffs could increase the chance of drug shortages and reduce access for patients.